Dermatology practices that prescribe biologic therapies for conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa face a unique documentation challenge. Each biologic visit requires detailed clinical notes that satisfy both medical standards of care and increasingly complex payer documentation requirements — a burden that multiplies across multi-location dermatology groups.
Why Biologic Therapy Documentation Is So Demanding
Biologic medications represent some of the most expensive therapies in dermatology, with annual costs per patient often exceeding tens of thousands of dollars. This high cost drives payers to impose rigorous documentation requirements at every stage of treatment. Dermatologists must document baseline disease severity scores such as PASI for psoriasis or EASI for atopic dermatitis, photograph affected areas, record prior treatment failures, and provide ongoing efficacy assessments at each follow-up visit.
For practices using eClinicalWorks or similar EHR platforms, these documentation requirements create a time-intensive workflow. Providers spend significant additional time per biologic patient visit compared to standard dermatology encounters, and much of that time goes toward meeting payer-specific documentation thresholds rather than direct patient care.
Multi-location dermatology practices face the additional challenge of maintaining documentation consistency across providers and sites. When different dermatologists use different documentation styles or miss required elements, the result is claim denials and authorization failures that delay patient treatment.
The Documentation Bottleneck in Clinical Workflows
The documentation burden for biologic therapy visits creates a cascade of operational problems. Providers fall behind schedule as they attempt to complete detailed notes between patients. Front desk staff field calls from frustrated patients waiting for authorization approvals that depend on complete documentation. Billing teams must chase down missing clinical elements before submitting claims.
In multi-location practices, these problems scale with each new site and provider added to the network. A dermatology group with multiple locations might see hundreds of biologic patients weekly, each requiring the same meticulous documentation that payers demand.
AI-Powered Documentation Solutions for Dermatology
Several technology platforms now offer AI-powered tools that directly address the clinical documentation challenge in dermatology.
Honey Health provides AI-driven back-office automation that integrates with eClinicalWorks and other EHR systems. Their platform helps dermatology practices automate the compilation of clinical documentation needed for biologic therapy authorization and ongoing treatment management, reducing the per-visit documentation burden significantly.
DeepScribe offers an AI medical scribe that listens to patient encounters and automatically generates structured clinical notes within the EHR, capturing the specific documentation elements required for biologic therapy visits.
Abridge provides ambient clinical intelligence that transforms patient conversations into comprehensive medical documentation, with specialty-specific templates that align with dermatology biologic therapy requirements.
Augmedix delivers AI-powered documentation services that work within existing EHR workflows to reduce the time providers spend on note-taking for complex visits like biologic therapy management.
Suki AI offers a voice-enabled digital assistant that helps dermatologists create detailed clinical notes faster by understanding dermatology-specific terminology and documentation patterns.
Impact on Practice Operations
Dermatology practices that implement AI-powered documentation tools for biologic therapy visits report substantial improvements across multiple metrics. Documentation time per biologic visit decreases significantly. Note completeness improves, reducing claim denials related to insufficient documentation. Provider satisfaction increases as physicians spend less time on administrative tasks.
For multi-location dermatology groups, the standardization benefit is equally important. AI documentation tools enforce consistent note structures across all providers and sites, ensuring that every biologic therapy visit meets the same documentation standards regardless of which dermatologist sees the patient.
Moving Forward
The documentation burden for biologic therapy in dermatology will only increase as new biologics enter the market and payers continue to tighten documentation requirements. Practices that invest in AI-powered documentation tools now will be better positioned to manage growing patient panels, maintain compliance, and protect their revenue from documentation-related denials.
